Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Thomas Schirrmann, Jürgen Krauss, Michaela AE Arndt, Susanna M Rybak & Stefan Dübel. (2009) Targeted therapeutic RNases (ImmunoRNases). Expert Opinion on Biological Therapy 9:1, pages 79-95.
Read now
Read now
Camillo Porta, Chiara Paglino & Luciano Mutti. (2008) Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma. Biologics: Targets and Therapy 2:4, pages 601-609.
Read now
Read now
Intae Lee. (2008) Ranpirnase (Onconase®), a cytotoxic amphibian ribonuclease, manipulates tumour physiological parameters as a selective killer and a potential enhancer for chemotherapy and radiation in cancer therapy. Expert Opinion on Biological Therapy 8:6, pages 813-827.
Read now
Read now
Articles from other publishers (46)
Marta Menegazzi & Giovanni Gotte. (2022) Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections. International Journal of Molecular Sciences 23:12, pages 6556.
Crossref
Crossref
Elisa De Tomi, Rachele Campagnari, Elisa Orlandi, Alessia Cardile, Valentina Zanrè, Marta Menegazzi, Macarena Gomez-Lira & Giovanni Gotte. (2022) Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 Melanoma Cells Correlates with the Downregulation of Specific Onco-Proteins. International Journal of Molecular Sciences 23:3, pages 1647.
Crossref
Crossref
Jessica Castro, Giusy Tornillo, Gerardo Ceada, Beatriz Ramos-Neble, Marlon Bravo, Marc Ribó, Maria Vilanova, Matthew J. Smalley & Antoni Benito. (2021) A Nuclear-Directed Ribonuclease Variant Targets Cancer Stem Cells and Inhibits Migration and Invasion of Breast Cancer Cells. Cancers 13:17, pages 4350.
Crossref
Crossref
Todd G. Smith, Felix R. Jackson, Clint N. Morgan, William C. Carson, Brock E. Martin, Nadia Gallardo-Romero, James A. Ellison, Lauren Greenberg, Thomas Hodge, Luis Squiquera, Jamie Sulley, Victoria A. Olson & Christina L. Hutson. (2020) Antiviral Ranpirnase TMR-001 Inhibits Rabies Virus Release and Cell-to-Cell Infection In Vitro. Viruses 12:2, pages 177.
Crossref
Crossref
Santiago Ruiz-Martínez, Jessica Castro, Maria Vilanova, Marta Bruix, Douglas V. Laurents, Marc Ribó & Antoni Benito. (2017) A truncated apoptin protein variant selectively kills cancer cells. Investigational New Drugs 35:3, pages 260-268.
Crossref
Crossref
Anna Vert, Jessica Castro, Marc Ribó, Antoni Benito & Maria Vilanova. (2016) Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase. Oncotarget 8:7, pages 11692-11707.
Crossref
Crossref
Gargi K. Vora, Hakan Demirci, Brian Marr & Prithvi Mruthyunjaya. (2017) Advances in the management of conjunctival melanoma. Survey of Ophthalmology 62:1, pages 26-42.
Crossref
Crossref
Yukiko Kariya, Takeo Tatsuta, Shigeki Sugawara, Yoshinobu Kariya, Kazuo Nitta & Masahiro Hosono. (2016) RNase activity of sialic acid-binding lectin from bullfrog eggs drives antitumor effect via the activation of p38?MAPK to caspase-3/7 signaling pathway in human breast cancer cells. International Journal of Oncology.
Crossref
Crossref
Miaonan Sun, Huichun Tang, Yan Gao, Xinxuan Dai, Yue Yuan, Chunmei Zhang & Dejun Sun. (2016) Constitutive expression and anticancer potency of a novel immunotoxin onconase-DV3. Oncology Reports.
Crossref
Crossref
Xiaomin Wang & Zhanyun Guo. (2015) Anti-gliomas Effect of Chlorotoxin-Conjugated Onconase at High Dose. Cell Biochemistry and Biophysics 73:2, pages 389-392.
Crossref
Crossref
Christian Cremer, Tim Vierbuchen, Lea Hein, Rainer Fischer, Stefan Barth & Thomas Nachreiner. (2015) Angiogenin Mutants as Novel Effector Molecules For the Generation of Fusion Proteins With Increased Cytotoxic Potential. Journal of Immunotherapy 38:3, pages 85-95.
Crossref
Crossref
XIAOMIN WANG & ZHANYUN GUO. (2015) Chlorotoxin-conjugated onconase as a potential anti-glioma drug. Oncology Letters 9:3, pages 1337-1342.
Crossref
Crossref
Christian Cremer, Grit Hehmann-Titt, Sonja Schiffer, Georg Melmer, Paolo Carloni, Stefan Barth & Thomas Nachreiner. 2015. Resistance to Immunotoxins in Cancer Therapy. Resistance to Immunotoxins in Cancer Therapy
185
219
.
Katarzyna Kurpiewska, Gerard Torrent, Marc Ribó, Joanna I. Loch, Maria Vilanova & Krzysztof Lewiński. (2014) Investigating the effects of double mutation C30A/C75A on onconase structure: Studies at atomic resolution. Biopolymers 101:5, pages 454-460.
Crossref
Crossref
Yan-Ping Shih, Chi-Chi Chou, Yi-Ling Chen, Kai-Fa Huang & Andrew H.- J. Wang. (2014) Linked Production of Pyroglutamate-Modified Proteins via Self-Cleavage of Fusion Tags with TEV Protease and Autonomous N-Terminal Cyclization with Glutaminyl Cyclase In Vivo. PLoS ONE 9:4, pages e94812.
Crossref
Crossref
XIAO-MIN WANG & ZHAN-YUN GUO. (2013) Recombinant expression, different downstream processing of the disulfide-rich anti-tumor peptide Ranpirnase and its effect on the growth of human glioma cell line SHG-44. Biomedical Reports 1:5, pages 747-750.
Crossref
Crossref
Sumit Goswami, Wei Wang, Tsutomu Arakawa & Satoshi Ohtake. (2013) Developments and Challenges for mAb-Based Therapeutics. Antibodies 2:4, pages 452-500.
Crossref
Crossref
Wojciech Ardelt. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals
337
353
.
Henrike Westekemper, Michael Freistuehler, Norbert Bornfeld, Klaus-Peter Steuhl, Max Scheulen & Ralf A. Hilger. (2012) Chemosensitivity of conjunctival melanoma cell lines to target-specific chemotherapeutic agents. Graefe's Archive for Clinical and Experimental Ophthalmology 251:1, pages 279-284.
Crossref
Crossref
Meng Qiao, Li-Dong Zu, Xiao-Hong He, Ru-Ling Shen, Qing-Cheng Wang & Mo-Fang Liu. (2012) Onconase downregulates microRNA expression through targeting microRNA precursors. Cell Research 22:7, pages 1199-1202.
Crossref
Crossref
Jo E. Lomax, Chelcie H. Eller & Ronald T. Raines. 2012. Protein Engineering for Therapeutics, Part A. Protein Engineering for Therapeutics, Part A
273
290
.
Daniel E. Holloway, Umesh P. Singh, Kuslima Shogen & K. Ravi Acharya. (2011) Crystal structure of Onconase at 1.1 Å resolution – insights into substrate binding and collective motion. The FEBS Journal 278:21, pages 4136-4149.
Crossref
Crossref
Pere Tubert, Montserrat Rodríguez, Marc Ribó, Antoni Benito & Maria Vilanova. (2010) The nuclear transport capacity of a human-pancreatic ribonuclease variant is critical for its cytotoxicity. Investigational New Drugs 29:5, pages 811-817.
Crossref
Crossref
C M Goparaju, J D Blasberg, S Volinia, J Palatini, S Ivanov, J S Donington, C Croce, M Carbone, H Yang & H I Pass. (2011) Onconase mediated NFKβ downregulation in malignant pleural mesothelioma. Oncogene 30:24, pages 2767-2777.
Crossref
Crossref
Marc Ribó, Antoni Benito & Maria Vilanova. 2011. Ribonucleases. Ribonucleases
55
88
.
Thomas J. Rutkoski, John A. Kink, Laura E. Strong, Christine I. Schilling & Ronald T. Raines. (2010) Antitumor Activity of Ribonuclease Multimers Created by Site-Specific Covalent Tethering. Bioconjugate Chemistry 21:9, pages 1691-1702.
Crossref
Crossref
Mary Frances McAleer, Reza J. Mehran & Anne Tsao. 2010. Lung Cancer. Lung Cancer
435
465
.
Rebecca F. Turcotte, Luke D. Lavis & Ronald T. Raines. (2009) Onconase cytotoxicity relies on the distribution of its positive charge. FEBS Journal 276:14, pages 3846-3857.
Crossref
Crossref
Anne S. TsaoIgnacio WistubaJack A. RothHedy Lee Kindler. (2009) Malignant Pleural Mesothelioma. Journal of Clinical Oncology 27:12, pages 2081-2090.
Crossref
Crossref
Claudia De Lorenzo & Giuseppe D’Alessio. (2009) Human anti‐ErbB2 immunoagents – immunoRNases and compact antibodies. The FEBS Journal 276:6, pages 1527-1535.
Crossref
Crossref
Rebecca F. Turcotte & Ronald T. Raines. (2008) Interaction of onconase with the human ribonuclease inhibitor protein. Biochemical and Biophysical Research Communications 377:2, pages 512-514.
Crossref
Crossref
Chuang-Xin Lu, Ke-Jun Nan & Yan Lei. (2008) Agents from amphibians with anticancer properties. Anti-Cancer Drugs 19:10, pages 931-939.
Crossref
Crossref
Rebecca F. TurcotteRonald T. Raines. (2008) Design and Characterization of an HIV-Specific Ribonuclease Zymogen. AIDS Research and Human Retroviruses 24:11, pages 1357-1363.
Crossref
Crossref
Amanda K Beck, Harvey I Pass, Michele CarboneHaining Yang. (2008) Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies. Future Oncology 4:3, pages 341-349.
Crossref
Crossref
Helene F Rosenberg. (2008) RNase A ribonucleases and host defense: an evolving story. Journal of Leukocyte Biology 83:5, pages 1079-1087.
Crossref
Crossref
Olga N. Ilinskaya, Andreas Koschinski, Holger Repp, Vladimir A. Mitkevich, Florian Dreyer, J. Martin Scholtz, C. Nick Pace & Alexander A. Makarov. (2008) RNase-induced apoptosis: Fate of calcium-activated potassium channels. Biochimie 90:5, pages 717-725.
Crossref
Crossref
Luciano Mutti & Giovanni Gaudino. (2008) The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma. Oncology Reviews 2:1, pages 61-65.
Crossref
Crossref
J Eugene Lee & Ronald T Raines. (2008) Ribonucleases as Novel Chemotherapeutics. BioDrugs 22:1, pages 53-58.
Crossref
Crossref
J. Eugene Lee, Euiyoung Bae, Craig A. Bingman, George N. PhillipsJrJr & Ronald T. Raines. (2008) Structural Basis for Catalysis by Onconase. Journal of Molecular Biology 375:1, pages 165-177.
Crossref
Crossref
Avvaru N. Suhasini & Ravi Sirdeshmukh. (2007) Onconase action on tRNALys3, the primer for HIV-1 reverse transcription. Biochemical and Biophysical Research Communications 363:2, pages 304-309.
Crossref
Crossref
Olga N. Ilinskaya, Pavel V. Zelenikhin, Irina Yu. Petrushanko, Vladimir A. Mitkevich, Vladimir S. Prassolov & Alexander A. Makarov. (2007) Binase induces apoptosis of transformed myeloid cells and does not induce T-cell immune response. Biochemical and Biophysical Research Communications 361:4, pages 1000-1005.
Crossref
Crossref
Franziska Leich, Nadine Stöhr, Anne Rietz, Renate Ulbrich-Hofmann & Ulrich Arnold. (2007) Endocytotic Internalization as a Crucial Factor for the Cytotoxicity of Ribonucleases. Journal of Biological Chemistry 282:38, pages 27640-27646.
Crossref
Crossref
Umesh P. Singh, Wojciech Ardelt, Shailendra K. Saxena, Daniel E. Holloway, Eugene Vidunas, Hung-Suen Lee, Abha Saxena, Kuslima Shogen & K. Ravi Acharya. (2007) Enzymatic and Structural Characterisation of Amphinase, a Novel Cytotoxic Ribonuclease from Rana pipiens Oocytes. Journal of Molecular Biology 371:1, pages 93-111.
Crossref
Crossref
Ester Boix & M. Victòria Nogués. (2007) Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence. Molecular BioSystems 3:5, pages 317.
Crossref
Crossref
Roohi Ismail-KhanLary A. RobinsonCharles C WilliamsJr.Jr., Christopher R. GarrettGerold BeplerGeorge R. Simon. (2017) Malignant Pleural Mesothelioma: A Comprehensive Review. Cancer Control 13:4, pages 255-263.
Crossref
Crossref
Ulrich Arnold & Renate Ulbrich-Hofmann. (2006) Natural and engineered ribonucleases as potential cancer therapeutics. Biotechnology Letters 28:20, pages 1615-1622.
Crossref
Crossref